Dysregulation of BPI protein function and high concentration of ANCA against BPI, which we found in UC/PSH, suggest an important influence of prolonged GN bacterial stimulation on the break of tolerance and might be targets for future, early immunomodulatory therapy in the initial phase of UC/PSC. This evidence concerns the gene BPI and ganglioneuroma.